Carboplatin/Paclitaxel/Pembrolizumab Followed by Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab that can be used for the treatment of non-small cell lung cancer (NSCLC) and breast cancer.

**Synonyms:** - Carboplatin-Paclitaxel-Pembrolizumab Followed by Pembrolizumab - Carboplatin/Keytruda/Taxol Followed by Keytruda - Carboplatin/Paclitaxel/Pembrolizumab Followed by Pembrolizumab - Pembrolizumab Plus Paclitaxel/Carboplatin Followed by Pembrolizumab